High to moderate inhibitory activities towards cholinesterase enzymes, α–amylase and lipase were reported for both species, thus suggesting that further work should be carried out aiming to explore its possible application in the treatments of neurodegenerative diseases and in the management of T2DM, obesity and hyperlipidemia. The gene discussed is BCHE; the disease is neurodegenerative disease.